menu Search

Empowering Healthcare Decisions.
Right at the point of Care.

Search
Powered by AI - Try searching for:
special reports VIEW ALL
PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.
Infectious-Diseases PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.

Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.

31 Mar 2026
Multi-Specialty StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility

A comprehensive review of obstetrical dilemma in endometriosis and infertility  

16 Mar 2026
StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility
Infectious-Diseases Product Highlight-Arexvy

Resp syncytial virus (RSV) vaccine [recombinant, adjuvanted (RSVPreF3 antigen, AS01E adjuvant system)] powder and suspension for suspension for injection 120 mcg/0.5 mL (1 dose)

22 Feb 2026
Product Highlight-Arexvy
Multi-Specialty Pharma head: Technology will disrupt all aspects of healthcare

Healthcare is fast shifting towards the digital age, with all stakeholders rushing to join the digital era. As major players in the healthcare industry, pharmaceutical companies are not spared the rush. MIMS Doctor speaks to Suresh Pragasam, regional general manager, Southeast Asia, Mundipharma Pharmaceutical, for his views on the uptake of technology and the digitization of healthcare and Mundipharma’s efforts to keep abreast with the trends.

22 Feb 2026 by Pank Jit Sin
Pharma head: Technology will disrupt all aspects of healthcare
top medical news VIEW ALL
Advertisement
Advertisement
Advertisement
Drug Updates VIEW ALL
New Molecule 3 new
Lazcluze Show more →
New Indication 4 new
Adcetris Show more →
New Brand 5 new
Lypstaplus Show more →
Pill Identifier
Enter numbers or letters stamped on the pill (e.g., L484, M 30)...
#1 Medical Resource Since 1963

What is MIMS

For over 60 years, MIMS has served as Asia-Pacific region's leading clinical drug dictionary and medical decision-support platform, trusted by over 2.1 million healthcare professionals. MIMS delivers independent, evidence-based prescription drug monographs, multi-drug interaction checks, and localized regulatory guidelines designed to support confident decision-making at the point of care.
  • Clinical Independence
  • Evidence-based Data
  • Regulatory Alignment
Learn More About Us
Trusted by 2.1 million HCPs
17 Countries & Regions
Australia Malaysia Philippines Singapore Vietnam Thailand

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs